Lipid metabolism: new approaches to old problems

Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Atherosclerosis·2025

Acquired liver fat is a key determinant of serum lipid alterations in healthy monozygotic twins.

Obesity (Silver Spring, Md.)·2013

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Diabetologia·2012

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study.

Diabetologia·2011

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.

Diabetologia·2007

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus.

Diabetologia·2007

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026

HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading?

Current opinion in lipidology·2026

Uncoupling of energy metabolism and myocardial function in early left atrial dysfunction: a metabolomics study.

Frontiers in cardiovascular medicine·2026

Targeted metabolomics identifies associations of plasma ceramides and their ratios with incident type 2 diabetes mellitus.

Acta diabetologica·2026

Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis.

Journal of diabetes investigation·2026

Multi-Omics Analysis Reveals Abnormal Metabolism of Lysophosphatidylinositol in Nasal Polyp.

Allergy, asthma & immunology research·2026

Adipose Tissue Palmitoylation Cycling Mediates Insulin Resistance and Preservation of β-Cell Function in Mice.

Diabetes·2026

Clinical and metabolic characteristics of acquired partial lipodystrophy: insights from a multicenter study.

Journal of endocrinological investigation·2026

Related Experiment Videos

Lipid metabolism: new approaches to old problems

Related Concept Videos

Genetically determined increase in apolipoprotein C-III (APOC3 gain-of-function) delays very low-density lipoprotein clearance in humans.

Acquired liver fat is a key determinant of serum lipid alterations in healthy monozygotic twins.

Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience.

Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study.

Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance.

Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus.

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

HDL and ASCVD: is high HDL-C protective, harmful, or simply misleading?

Uncoupling of energy metabolism and myocardial function in early left atrial dysfunction: a metabolomics study.

Targeted metabolomics identifies associations of plasma ceramides and their ratios with incident type 2 diabetes mellitus.

Liraglutide reprograms vascular smooth muscle cell metabolism to suppress extracellular matrix remodeling in diabetic atherosclerosis.

Multi-Omics Analysis Reveals Abnormal Metabolism of Lysophosphatidylinositol in Nasal Polyp.

Adipose Tissue Palmitoylation Cycling Mediates Insulin Resistance and Preservation of β-Cell Function in Mice.

Clinical and metabolic characteristics of acquired partial lipodystrophy: insights from a multicenter study.

Related Experiment Videos

Lipid metabolism: new approaches to old problems

Related Concept Videos

Related Articles